乳腺癌转移的一个重要基因特征揭示了可向的途径
Yiqun Zhang1, Fengju Chen1, Marija Balic2,3,4
1Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, One Baylor Plaza, MS305, Houston, TX, 77030, USA.
Breast cancer research : BCR
|June 12, 2024
概括
研究人员通过分析原发性瘤与转移中的基因表达,确定了乳腺癌转移的基本基因特征. 这种签名预测了患者的结果,并突出了参与癌症传播的关键细胞过程.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 原发性和转移性乳腺瘤之间的基因表达差异可以揭示转移途径.
- 瘤样本是异质的,因此难以区分癌细胞生物学与诸如活检部位等混因素.
研究的目的:
- 识别乳腺癌转移至关重要的基因,过出与活检部位差异相关的基因.
- 建立转移的"基本特征"并评估其对患者结果的预测价值.
主要方法:
- 来自152名患者的RNA测序数据 (BIG-AURORA数据集) 的对分析,以确定差异表达的基因.
- 从乳腺癌细胞系中整合基于CRISPR的基本性数据,以过对扩散至关重要的基因.
主要成果:
- 在转移中调节的基因中,很大一部分基因对癌细胞增殖至关重要,形成了264个基因的"基本特征".
- 这种基本的签名准确地预测了使用初级瘤表达数据的患者结果.
- 发现的关键途径包括蛋白酶体降解,氧化酸化和代谢重编程,其中MYC,MAX,HDAC3和HCFC1是关键的转录因子.
结论:
- 鉴定到的基本基因特征反映了转移性癌细胞内在的真正的生物学变化.
- 这个签名对治疗策略有重大影响,包括应用现有的治疗方法和开发新的治疗方法.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


